Document Detail

Analysis of 65 Turkish patients with congenital aplastic anemia (Fanconi anemia and non-Fanconi anemia): Hacettepe experience.
MedLine Citation:
PMID:  9212176     Owner:  NLM     Status:  MEDLINE    
During the last 14 years, 65 unrelated patients were diagnosed as having constitutional aplastic anemia (CAA). In 52 of 65 patients the diepoxybutane (DEB) test was positive. Comparison of several hematological and clinical parameters in Fanconi anemia (FA) (DEB+) and non-Fanconi anemia (non-FA)(DEB ) patients disclosed no statistically significant differences. The study indicated that in Turkey there were no peculiarities in associated congenital abnormalities in FA and non-FA. The rate of consanguinity was 78% in FA and 46% in non-FA, suggesting that also among the non-FA group recessively inherited disorders are hidden. The mean age at diagnosis in FA was 7.7+/-4.4 (1.8-12) and in non-FA 7.8+/-3.8 (2-15) years. Nine out of 52 FA and five out of 13 non-FA patients died during the follow-up period. Five of the 52 FA patients developed malignancies, three of them had acute myeloblastic leukemia (AML), one a squamous cell carcinoma of the gingiva, and another a hepatocellular carcinoma. Peliosis hepatica occurred in three of the FA and one of the non-FA patients. A total of seven patients stayed in remission without any medication. The remaining 58 patients were given 2-5 mg/kg of oxymetholone and 5 mg prednisolone treatment. Because of sustained remission, oxymetholone therapy was terminated in four of the 45 FA and two of the 13 non-FA patients. Detailed examination of the pedigrees of all of patients indicated the presence of multiple congenital anomalies. In seven of 52 FA and one of 13 non-FA patients there was increased risk for AML and/or other cancers among family members.
C Altay; M Alikaşifoglu; A Kara; E Tunçbilek; N Ozbek; T M Schroeder-Kurth
Related Documents :
21986556 - Mitochondrial trna valine as a recurrent target for mutations involved in mitochondrial...
1655216 - Serum immunoerythropoietin levels in patients with cancer receiving cisplatin-based che...
505076 - Fever in megaloblastic anemia.
9671336 - Epoetin alfa: into the new millennium.
18028436 - Plasma mmp-2-timp-2 complex levels measured during follow-up predict a risk of relapse ...
21474626 - Value of mr venography for detection of internal jugular vein anomalies in multiple scl...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Clinical genetics     Volume:  51     ISSN:  0009-9163     ISO Abbreviation:  Clin. Genet.     Publication Date:  1997 May 
Date Detail:
Created Date:  1997-08-19     Completed Date:  1997-08-19     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0253664     Medline TA:  Clin Genet     Country:  DENMARK    
Other Details:
Languages:  eng     Pagination:  296-302     Citation Subset:  IM    
Department of Pediatrics, Pediatric Hematology Unit, Ihsan Dogramaci Children's Hospital, Hacettepe University, Ankara, Turkey.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Abnormalities, Multiple
Anemia, Aplastic / congenital*,  drug therapy,  genetics,  metabolism
Child, Preschool
Disease Progression
Epoxy Compounds / analysis
Fanconi Anemia / drug therapy,  genetics*,  metabolism
Follow-Up Studies
Oxymetholone / therapeutic use
Reg. No./Substance:
0/Epoxy Compounds; 1464-53-5/erythritol anhydride; 434-07-1/Oxymetholone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  MN blood group affects response of serum LDL cholesterol level to a low fat diet.
Next Document:  High prevalence of a novel mutation in the exon 4 of the low-density lipoprotein receptor gene causi...